PARIS (Reuters) – Moderna (NASDAQ:) Inc is on track to deliver between 600 million and 1 billion doses of its COVID-19 vaccine this year, Chief Executive Stephane Bancel said on Thursday.
Bancel said Moderna had orders for 500 million doses of its vaccine and could comfortably make at least 600 million doses. He told a conference organised by Oddo BHF that the group was working to meet or even exceed a target for 1 billion doses, however.
Bancel said it was still not clear how long the antibodies generated by the vaccines would last, but added that it could potentially be a couple of years.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.